Research

A new study suggests benefits to patient health and society top billions of dollars, or more, if adherence to wet age-related macular degeneration treatments could be improved.

Research by Jakub Hlavka and colleagues suggests a combination of brief cognitive tests and blood-based biomarker tests will allow primary care physicians to identify patients with potential early stage Alzheimer’s disease efficiently and triage them for further evaluation.

Population aging in Mexico as in the United States is expected to accelerate over the next thirty years, and the proportion of individuals 65 and older will triple to approximately 20 percent by 2050 in both nations. Older people of Mexican origin are at high risk of protracted periods of poor health, a reality exacerbated […]

Insurance coverage can change the health trajectory of people with diabetes by facilitating timely diabetes diagnosis and management.

Most hospital systems span across markets and states with higher system participation were more likely to have below median per capita hospital spending.

Suboptimal adherence to chronic medications undermines treatment effectiveness and costs the U.S. as much as $289 billion annually. This is the first study to analyze the impact of extended-release formulations on long-term adherence.

Children, adolescents, and young adults treated in pediatric emergency departments are much less likely to be prescribed opioids compared to patients of similar age and ailment treated at general EDs.

Reducing the incidence of four common cancers (breast, colon, lung, and prostate cancer), diabetes and stroke by 50 percent would generate nearly $900 billion in social value for California between 2018 and 2040. Just a 10 percent decline generates $175 billion over the same period.

Should Congress reauthorize funding for the Patient-Centered Outcomes Research Institute (PCORI)? Professor William Padula writes the PCORI can generate research relevant for shifting to value-based healthcare.